Currently viewing the tag: "qualifying patient"

Continue Reading

Arizona has one of the most up-to-date and tightly regulated Medical Marijuana Programs in the country. The state has learned from the “Wild-West” MMJ states like California & Colorado, and designed a very efficient and tightly regulated industry for “ganjapreneurs” to compete in. Having these strict guidelines to abide by works in favor […]

Continue Reading

ADHS accepts petitions to add a debilitating medical condition to the list of debilitating medical conditions for the Medical Marijuana Program in January and July of each year.

Public Comment Period for January 2012 Petitions

During the month of January 2012, ADHS accepted petitions to add to the list of debilitating medical conditions. Several of […]

Continue Reading

The Arizona Medical Marijuana Program is now accepting renewal applications. For additional information about the renewal process, please visit the Renewal Information page of the AZDHS website.

Arizona Medical Marijuana Program Registry Identification Cardholders (cardholders) must renew their cards annually. There are various steps required to complete the renewal process that Green […]

Continue Reading

January 13th, 2012 by Will Humble

Last May (after receiving a threatening letter from the Arizona U.S Attorney’s Office) the Governor suspended the dispensary portion of the Arizona Medical Marijuana Act with a genuine concern that state employees would be federally prosecuted.  Last year, we asked the federal court to provide us […]

Continue Reading

In Pot We Trust

On December 15, 2011 By

This is an incredible documentary about medical marijuana and the relief this miracle plant can bring to Arizona medical marijuana patients.

Continue Reading

Cannabis Science Reports On Two Cannabis-Based Drug Release Programs

By Michael Roberts Wed., Aug. 12 2009, Denver Westword
COLORADO SPRINGS, Colo.–(BUSINESS WIRE)–Cannabis Science, Inc. (OTCBB: CBIS) an emerging pharmaceutical cannabis company is pleased to announce that it has completed its review of the FDA licensing requirements and has made key progress with mapping out […]

Continue Reading

Brain Cancer. The effectiveness of cannabinoids in fighting glioblastoma multiforme (GBM), a form of brain cancer that is highly resistant to current treatments, has been demonstrated in numerous preclinical studies. New research shows that a combination of THC, CBD, and temozolomide (TMZ) “remarkably reduces the growth of glioma.” The study revealed tumor growth is inhibited […]

Continue Reading

Italian researchers used an animal model of multiple sclerosis to investigate the efficacy of cannabis extracts on motor symptoms. They found that treating with a THC-rich extract over time “resulted in a significant reduction of neurological deficits,” that treatment with CBD affected only the relapse phase, and that combined THC-CBD treatment was ineffective. They suggest […]

Continue Reading

Scientists at Florida State University investigated the role of the endocannabinoid system in endometriosis, a disease common in women that is associated with severe pain and is difficult to treat. Using a rat model, they discovered CB1 cannabinoid receptors throughout the abnormal growths that characterize endometriosis. Blocking those CB1 receptors increased pain sensitivity, while stimulating […]

Continue Reading